Board summary
Key figures
47,411
Registered population
60.1% aged 18–64
17.3%
Aged 65+
ICB 20.0% · England 17.9%
21.1%
Ethnic minority (non-White)
18.6% Asian · England 9.6%
53.4%
In IMD quintile 1
ICB 30.6% · England 21.0%
~22,253
Core20 residents (est.)
Resident basis; registered basis ~27,621 · see page 3
7,082
Hypertension register
+3.51% in 3 yrs · England +5.60%
689
SMI register
27.6% of Blackburn with Darwen (LAD)'s
909
COPD register
Reviews +0.48% in 3 yrs
Forecast to 2030
7,696
Hypertension patients, 2030
+614 on today
87.7%
QRISK ≥20% on statins, 2030
+9.58pp over 3 yrs
3.7%
Cancer prevalence, 2030
England 4.5%
Three things the board should see
Early MMR uptake and pre-school booster lag.
In Q1 2025/26, 24-month MMR1 is 78.5% (below the 95.0% target by 16.5 pp), and age-5 MMR drops 9.7 pp from 96.3% to 86.6%.
Cervical screening in younger women trails England.
Coverage in women aged 25-49 is 56.4% against 59.4% in the borough and 66.8% in England, falling 5.3% from 2023 to 2025 (England -1.0%).
Register blood pressure control and reviews exceed England.
Hypertension treated to target reaches 72.8% (England 70.3%), alongside 85.7% for annual COPD reviews (England 76.4%) and 89.4% for heart failure reviews (England 78.5%).
Population, age and ethnicity
The PCN serves 47,411 patients with 22.6% aged 0-17 and marked ethnic variations
Across 47,411 registered patients, 22.6% are aged 0-17, compared with 24.0% in Blackburn with Darwen, 19.6% in the ICB and 19.6% in England. Patients aged 65+ represent 17.3%, against 13.5% in Blackburn with Darwen, 20.0% in the ICB and 17.9% in England. Associated area Census estimates record 18.6% Asian or Asian British residents, against 35.7% in Blackburn with Darwen, 9.4% in the ICB and 9.6% in England. Practice catchments diverge sharply: Asian residency is 62.4% at Family Practice and 55.6% at Limefield Surgery, but 9.9% at Redlam Surgery. Area Census estimates do not reflect registered patient ethnicity.
Age profile
65+: ICB 20.0%, England 17.9%
Ethnicity
Older people · falls rows are Blackburn with Darwen (LAD) local-authority (LA) data, not PCN
| Measure | Local | North West | England | Period |
|---|---|---|---|---|
| Falls admissions, 65+, per 100,000 (Blackburn with Darwen LA) | 1,724 | 2,071 | 1,958 | 2024/25 |
| Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN) | 85.7% | 82.9% | 81.9% | 2024/25 |
| Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN) | 56.4% | 56.6% | 57.4% | 2024/25 |
| Falls admissions, 65 to 79, per 100,000 (Blackburn with Darwen LA) | 951 | 1,021 | 955 | 2024/25 |
| Falls deaths, all ages, per 100,000 (Blackburn with Darwen LA) | 16.5 | 18.2 | 14.8 | 2022‑24 |
Deprivation and Core20
Core20 deprivation reaches 53.4% across the PCN and varies sharply by practice
Across the PCN, 53.4% of registered patients live in Core20 areas, against 59.6% in Blackburn with Darwen, 30.6% in the ICB and 21.0% in England. Core20 concentration is highest at Family Practice (93.2%), Redlam Surgery (64.0%) and Limefield Surgery (62.5%), while volume peaks at Little Harwood Health Centre (7,191 estimated patients) and Witton Medical Centre (5,554). Summed practice estimates (27,621) exceed the resident deciles 1 and 2 estimate (22,253), which may reflect differing population bases. Outreach requires balancing practice concentration with absolute patient volume.
% of patients in IMD quintile 1, by practice
Dashed line: England 21.0% · right column: Core20 patients, registered basis
PLUS groups and inclusion health
PLUS groups and inclusion health
689
SMI register
1.44% recorded prevalence
316
Learning disability register
0.66% recorded prevalence
26
Care homes, 788 beds
In the PCN catchment
9.9%
Provide unpaid care
Blackburn with Darwen (LAD), Census 2021
Severe mental illness prevalence is 1.4% (689 patients), above Blackburn with Darwen (1.3%), the ICB (1.2%) and England (1.0%). Learning disability prevalence is 0.7% (316 patients), compared with 0.6% across Blackburn with Darwen, the ICB and England. The PCN catchment contains 26 care homes with 788 beds.
Severe mental illness: physical health checks
SMI prevalence is 1.4% (England 1.0%). Physical health checks trail England: 76.2% of patients received blood pressure checks (England 83.4%) and 74.5% received BMI checks (England 82.1%). Uncompleted checks may leave physical cardiovascular risks unmonitored.
Clinical focus: hypertension and lipids
Clinical focus: hypertension and lipids
7,082
Hypertension register
+3.51%
Register growth, 3 yrs
Blackburn with Darwen (LAD) +4.97% · England +5.60%
+5.95pp
BP control, under 80
≤140/90 · +5.88pp aged 80+
+614
More patients by 2030
Forecast 7,696 (15.90%)
Hypertension case-finding and control
Blackburn West PCN records hypertension prevalence of 14.8% (7,082 patients), slightly below England (15.2%), Blackburn with Darwen (15.0%) and the ICB (17.2%). Three-year register growth was +3.5% (+0.5 pp) from 2023 to 2025, trailing England (+5.6%), the borough (+5.0%) and the ICB (+6.3%). Conversely, treatment to target reached 72.8%, outperforming England (70.3%), the borough (68.0%) and the ICB (70.3%), while BP control for under-80s reached 70.6% against 67.8% nationally. Slower register expansion alongside strong clinical management may indicate unrecorded hypertension rather than lower disease burden, meaning systematic case-finding should be prioritised across lower-prevalence practices.
Lipids and statins
Patients with QRISK ≥ 20% treated with lipid-lowering therapy reached 63.1%, slightly behind England (63.6%) and Blackburn with Darwen (66.0%), despite rising +17.9% (+9.6 pp) from 2023 to 2025 (England +6.2%). Reviewing eligible patients could support further uptake.
| Measure | Items | Cost / item | ICB | England | Annual spend |
|---|---|---|---|---|---|
| Lipid-modifying, 2026 | 86,230 | £2.60 | £1.64 | £1.86 | £224,198 |
| Cardiovascular (all), 2025 | 121,647 | £3.40 | £3.38 | £3.33 | £413,600 |
In 2026, lipid-modifying drugs cost £2.60 per item across 86,230 items (spending £224,198), above England (£1.86), the borough (£1.83) and the ICB (£1.64), costing £63,810 more than at England's unit cost. Higher unit costs than comparators may reflect formulary mix, presenting a focus for prescribing review.
Clinical focus: respiratory, cancer register and children
Clinical focus: respiratory, cancer register and children
Respiratory
+0.84%
Asthma reviews, PCN 3-yr % change
+4.44%
Asthma reviews, England 3-yr % change
−3.51%
Asthma prevalence, PCN 3-yr % change
Asthma prevalence is 6.8% (3,021 patients) and COPD prevalence is 1.9% (909 patients). Recorded annual reviews exceed national benchmarks: 69.2% for asthma (England 65.7%) and 85.7% for COPD (England 76.4%). However, over three years from 2023 to 2025, asthma registers fell 3.5% (England +0.5%) and COPD registers fell 2.1% (England +2.6%). Applying the review rate leaves an estimated 929 asthma patients unreviewed, indicating that strong review achievement on registers may mask contracting case ascertainment.
Cancer register and children's immunisation
Cancer prevalence is 3.4% (1,607 patients) against England's 3.8%. In Q1 2025/26, MMR1 uptake at 24 months is 78.5%, below the 95.0% target by 16.5 pp. At age 5, first-dose MMR reaches 96.3% but second-dose coverage drops by 9.7 pp to 86.6% (below the 95.0% target by 8.4 pp). Slower early uptake and pre-school dose drop-off leave young cohorts vulnerable to preventable outbreaks.
Dashed line: 95% national coverage target · solid tick: England
Early cancer diagnosis
Early cancer diagnosis
52.4%
Lancashire and South Cumbria ICB, stage 1–2
55.3%
England, 2022
75%
National ambition by 2028
~2,010
Extra early-stage cases a year to reach the ambition
| Stage 1–2 share by cancer type, 2022 | Lancashire and South Cumbria ICB | England | No usable stage | Staged cancers |
|---|---|---|---|---|
| Breast | 86.0% | 85.4% | 6% | 1,561 |
| Prostate | 42.4% | 53.2% | 11% | 1,404 |
| Lung | 31.1% | 33.8% | 15% | 1,374 |
| Bowel | 44.2% | 47.0% | 13% | 1,198 |
| Skin cancer | 86.1% | 87.8% | 21% | 519 |
In 2022, across NHS Lancashire and South Cumbria ICB, 52.4% of cancers with a known stage (4,642 of 8,863) were diagnosed at stage 1 or 2, against 55.3% in England and 22.6 pp below the 75.0% national ambition by 2028. Known-stage completeness was 74.6% (8,863 of 11,883 cancers). System-wide, reaching 75.0% would require about 2,010 additional early-stage cases annually. Meanwhile, PCN cervical screening coverage in women aged 25-49 is 56.4%, below England's 66.8%, falling 5.3% over three years (England -1.0%). Lower uptake may delay presentation, reinforcing the need for targeted primary care screening recall.
Cancer waits, diagnostics and community services
Cancer waits, diagnostics and community services
Cancer waits and diagnostics, Jul 2026 (provisional)
In Jul 2026, East Lancashire Hospitals NHS Trust achieved 81.5% on the 28-day faster diagnosis standard (exceeding the 75.0% standard) and 98.1% on 31-day treatment (standard 96.0%), but met 73.2% on the 62-day referral-to-treatment standard (standard 85.0%). Comparators on 62-day waits were 69.7% at Bolton NHS Foundation Trust, 75.0% at Lancashire Teaching Hospitals NHS Foundation Trust, 73.6% in NHS Lancashire and South Cumbria Integrated Care Board and 71.2% in England. For diagnostics, 32.7% waited 6+ weeks for cystoscopy at East Lancashire Hospitals NHS Trust (England 24.4%), while MRI waits of 6+ weeks were 0.4% (England 21.4%).
| Pathways within standard (%) | East Lancashire | Lancashire | Bolton | Lancashire and South Cumbria ICB | England |
|---|---|---|---|---|---|
| 28-day faster diagnosis (75%) | 81.50 | 82.90 | 80.48 | 78.39 | 79.32 |
| 31-day treatment (96%) | 98.11 | 89.43 | 96.50 | 93.62 | 92.50 |
| 62-day referral to treatment (85%) | 73.16 | 75.04 | 69.66 | 73.62 | 71.16 |
| Diagnostic waits over 6 weeks (%) | East Lancashire | Lancashire | Bolton | England |
|---|---|---|---|---|
| MRI | 0.43 | 2.41 | 2.05 | 21.40 |
| CT | 0.15 | 14.97 | 19.40 | 9.92 |
| Echocardiography | 0.00 | 13.85 | 3.48 | 28.48 |
| Colonoscopy | 0.95 | 0.00 | 1.33 | 30.83 |
| Gastroscopy | 1.16 | 0.00 | 2.06 | 29.02 |
| All 15 DM01 tests | 3.25 | 26.65 | 15.78 | 23.14 |
| Community services activity | Blackburn With Darwen residents | Lancashire and South Cumbria ICB |
|---|---|---|
| Care contacts | 535 | 193,720 |
| Referrals | 230 | 29,855 |
| Patients with a contact | 305 | 65,335 |
Community services (residents of Blackburn With Darwen), Jun 2026 (provisional). In Jun 2026 (provisional), community service contacts for Blackburn with Darwen residents recorded 195 of 535 contacts among adults aged 65+, representing 36.4% of total activity. With provider-level and PCN-level breakdowns not captured, these figures describe borough resident activity rather than PCN caseload. Community and intermediate care links remain vital as older residents navigate diagnostic and cancer pathways.
Practice variation and patient experience
Overall patient satisfaction varies by 32.5 pp across practices, spanning 58.0% to 90.6%
In 2025/26, overall QOF achievement ranged from 78.4% at Family Practice to 98.3% at Redlam Surgery against England's 92.5%. Clinical achievement reached 97.8% at Little Harwood Health Centre. However, vaccination achievement trailed England (55.2%) across five practices, falling to 15.6% at Family Practice and Oakenhurst Medical Practice across a 69.5 pp range.
GP Patient Survey by practice
| Practice | Responses | % in IMD Q1 | Phone easy | Request led to appt | Overall good |
|---|---|---|---|---|---|
| Witton | 105 | 49.2 | 79.8% | 76.8% | 90.6% |
| Oakenhurst | 109 | 44.7 | 63.4% | 75.5% | 83.8% |
| Redlam Surgery | 113 | 64.0 | 83.5% | 64.6% | 82.8% |
| Limefield Surgery | 99 | 62.5 | 76.4% | 71.5% | 79.2% |
| Little Harwood | 111 | 59.3 | 40.1% | 72.6% | 71.7% |
| Family Practice | 96 | 93.2 | 39.8% | 80.9% | 58.0% |
| England | — | ~21 | 56.9% | 71.6% | 76.7% |
Where the PCN lags
Dementia registers fell 15.9% over three years while heart failure reviews reached 89.4%
Between 2023 and 2025, dementia register prevalence fell 15.9% (England +6.0%, Blackburn with Darwen -7.4%, ICB +2.8%) and stroke fell 5.1% (England +2.3%, Blackburn with Darwen -1.0%, ICB +1.9%). Conversely, treatment on registers showed notable strengths: three-year change for patients with QRISK ≥ 20% on lipid-lowering therapy was +17.9% (England +6.2%), and diabetes statin treatment was +13.0% (England +2.1%). Additionally, 89.4% of heart failure patients had an annual review, exceeding England's 78.5%. Falling registers alongside strong recorded management may reflect under-detection or coding disparities, which diagnostic register audits would need to test.
3-year change · PCN vs England
Bars show the direction and scale of relative change. Orange: PCN · Grey: England.
Dementia register
Stroke register
COPD register
Cancer register
Alcohol record (psychosis)
QRISK statin treatment
Diabetes statin (no CVD)
BP control, under 80
What the data can't tell us: gaps and local assets
What the data can't tell us: gaps and local assets
| Local assets and voluntary sector | PCN | Blackburn with Darwen (LAD) | Asset | PCN | Blackburn with Darwen (LAD) |
|---|---|---|---|---|---|
| Care homes (catchment) | 26 (788 beds) | n/a | Schools (catchment) | 88 | n/a |
| Children's centres | 6 | 13 | Places of worship | 70 | 99 |
| Libraries | 4 | 6 | Primary schools (LA maintained) | 31 | 45 |
| Primary academies | 4 | 6 | Special schools | n/a | 1 |
0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.
Options for the PCN
Options for the PCN
Each option in full
Option 1
Childhood MMR catch-up and pre-school recall
In Q1 2025/26, 24-month MMR1 is 78.5% (16.5 pp below the 95.0% target; England 88.3%), and age-5 MMR drops 9.7 pp from 96.3% to 86.6% across 134 children. For discussion: audit 24-month and age-5 cohorts for missed MMR doses and offer flexible catch-up clinics and phone reminders. Moderate effort to run.
Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.
Policy anchor: 10 Year Health Plan, shift from sickness to prevention.
Option 2
Combined SMI physical health check outreach
SMI prevalence is 1.4% (689 patients vs England 1.0%), while 12-month BP checks are 76.2% (England 83.4%, LAD 77.1%, ICB 79.8%) and BMI checks are 74.5% (England 82.1%). For discussion: combine BP and BMI checks in medication reviews, assign outreach leads, and raise data sharing with mental health partners. Moderate effort to run.
Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.
Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.
Option 3
Hypertension case-finding and coding audit
Hypertension prevalence is 14.8% (7,082 patients) vs LAD 15.0% and England 15.2% (crude gap +19 to +139), with 2023 to 2025 growth +3.5% vs England +5.6%. For discussion: search records for uncoded raised BP readings and offer opportunistic checks, starting at Family Practice (7.3%) and Limefield Surgery (12.1%). Low cost, quick to run.
Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.
Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).
Provenance and audit trail
Provenance and audit trail
Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.
| Recommendation | Indicator(s) | Policy anchor | Data level |
|---|---|---|---|
| Culturally tailored access review (p2) | Asian / Asian British | Neighbourhood health framework · Core20PLUS5 approach | PCN |
| Two-track Core20 outreach (p3) | Core20 cohort (IMD quintile 1) | Core20PLUS5 · 10YHP equity test | PCN |
| SMI physical check outreach (p4) | SMI register with a BP check in the last 12 months | MHIS · From Harm to Hope | PCN |
| Hypertension case finding audit (p5) | Hypertension: QOF prevalence | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN |
| Pre-school MMR recall catch-up (p6) | MMR dose 2 coverage at age 5 | 10YHP sickness to prevention · 95% target | PCN |
| Cervical screening equity recall (p7) | Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs) | Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026 | PCN |
| Access and triage workflow review (p9) | GPPS easy to contact the practice by phone | 10YHP, hospital to community | Practice |
| Option 1 · Childhood MMR catch-up and pre-school recall (p12) | MMR dose 1 coverage at 24 months · MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 5 | 10YHP sickness to prevention · 95% target | PCN |
| Option 2 · Combined SMI physical health check outreach (p12) | Severe mental illness register · Severe mental illness: QOF prevalence · SMI register with a BP check in the last 12 months | MHIS · From Harm to Hope | PCN |
| Option 3 · Hypertension case-finding and coding audit (p12) | Hypertension register · Hypertension: QOF prevalence · Hypertension patients treated to target | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN & Practice |
Data sources
Data sources
Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.
| Dataset | Level | Period | Used for |
|---|---|---|---|
| Coplug indicator tables: census, deprivation and QOF measures | PCN & Practice | 2023 to 2025, projected to 2030; 2023 to 2024 | Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12 |
| MHCLG, Rough sleeping snapshot in England: autumn 2025 | Local authority | Autumn 2025 | Pages 2, 4 |
| OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) | PCN | 2024/25 | Pages 2, 4 |
| OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002) | Local authority | 2024/25; 2022-24 | Pages 2, 4 |
| ONS, Census 2021 TS039: provision of unpaid care (age-standardised) | Local authority | Census 2021 | Pages 2, 4 |
| QOF registers, prevalence and care processes (Coplug indicator tables) | Practice | 2023 to 2025, projected to 2030 | Pages 4, 5, 6, 7, 8, 10 |
| UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26 | PCN & Practice | Q1 2025/26 | Pages 4, 6 |
| UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026 | Local authority | 2025/26 season to 28 Feb 2026 | Pages 4, 6 |
| NHS England, Cancer Waiting Times: July 2026 monthly time series with revisions | ICB & Provider | Jul 2026 (provisional) | Pages 7, 8 |
| NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental data | ICB & Local authority | Jun 2026 (provisional) | Pages 7, 8 |
| NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026 | Provider | Jul 2026 | Pages 7, 8 |
| National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022 | ICB | 2022 | Pages 7, 8 |
| NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted) | Practice | Survey Jan-Apr 2026 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domain | Practice | 2025/26 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domain | Practice | 2025/26 | Page 9 |
| Coplug indicator catalogue — definitions, cohorts, policy anchors | Reference | Current | Evidence-base lines, page 13 |
Methods, data-quality notes and limitations
Methods, data-quality notes and limitations
Methods
Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.
Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.
Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.
Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.
